Latent versus productive infection: The alpha herpesvirus switch

Future Virology

Volumn 13, Issue 6, 2018, Pages 431-443

  Koyuncu, Orkide O ^a   Macgibeny, Margaret A ^a   Enquist, Lynn W ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

alpha herpesviruses; in vitro latency model; latency; reactivation

Indexed keywords

ALPHAHERPESVIRINAE; AXON; HUMAN; HUMAN ALPHAHERPESVIRUS 1; IN VITRO STUDY; LATENT VIRUS INFECTION; NERVE CELL CULTURE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; VIRUS REACTIVATION;

EID: 85047490211     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl-2018-0023     Document Type: Review

References (103)

1. Cohrs RJ, Gilden DH. Human herpesvirus latency. Brain Pathol. 11(4), 465-474 (2001).
2. Penkert RR, Kalejta RF. Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae 2(1), 3 (2011).
3. Honess RW, Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14(1), 8-19 (1974).
4. Roizman B, Whitley RJ. An inquiry into the molecular basis of HSV latency and reactivation. Ann. Rev. Microbiol. 67, 355-374 (2013).
5. Looker KJ, Magaret AS, May MT et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE 10(10), e0140765 (2015).
6. Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS ONE 10(1), e114989 (2015).
7. Moffat J, Ku CC, Zerboni L, Sommer M, Arvin A. VZV: pathogenesis and the disease consequences of primary infection. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E et al. (Eds). Cambridge University Press, Cambridge, UK (2007).
8. Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PG. Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J. Neurovirol. 9(2), 194-204 (2003).
9. Croen KD, Ostrove JM, Dragovic LJ, Straus SE. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl Acad. Sci. USA 85(24), 9773-9777 (1988).
10. Cheung AK. Detection of pseudorabies virus transcripts in trigeminal ganglia of latently infected swine. J. Virol. 63(7), 2908-2913 (1989).
11. Enquist LW, Tomishima MJ, Gross S, Smith GA. Directional spread of an alpha-herpesvirus in the nervous system. Vet. Microbiol. 86(1-2), 5-16 (2002).
12. Jones C. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin. Microbiol. Rev. 16(1), 79-95 (2003).
13. Richter ER, Dias JK, Gilbert JE, 2nd, Atherton SS. Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck. J. Infect. Dis. 200(12), 1901-1906 (2009).
14. Antinone SE, Shubeita GT, Coller KE et al. The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus. J. Virol. 80(11), 5494-5498 (2006).
15. Bohannon KP, Jun Y, Gross SP, Smith GA. Differential protein partitioning within the herpesvirus tegument and envelope underlies a complex and variable virion architecture. Proc. Natl Acad. Sci. USA 110(17), E1613-E1620 (2013).
16. Wolfstein A, Nagel CH, Radtke K, Dohner K, Allan VJ, Sodeik B. The inner tegument promotes herpes simplex virus capsid motility along microtubules in vitro. Traffic 7(2), 227-237 (2006).
17. Campbell ME, Palfreyman JW, Preston CM. Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. J. Mol. Biol. 180(1), 1-19 (1984).
18. Wilson AC, Cleary MA, Lai JS, LaMarco K, Peterson MG, Herr W. Combinatorial control of transcription: the herpes simplex virus VP16-induced complex. Cold Spring Harb. Symp. Quant. Biol. 58, 167-178 (1993).
19. Wysocka J, Herr W. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem. Sci. 28(6), 294-304 (2003).
20. Roizman B, Sears AE. An inquiry into the mechanisms of herpes simplex virus latency. Annu. Rev. Microbiol. 41, 543-571 (1987).
21. Hafezi W, Lorentzen EU, Eing BR et al. Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog. 8(5), e1002679 (2012).
22. Zaichick SV, Bohannon KP, Hughes A, Sollars PJ, Pickard GE, Smith GA. The herpesvirus VP1/2 protein is an effector of dynein-mediated capsid transport and neuroinvasion. Cell Host Microbe 13(2), 193-203 (2013).
23. Preston CM, Efstathiou S. Molecular basis of HSV latency and reactivation. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E et al. (Eds). Cambridge University Press, Cambridge, UK, (2007).
24. Lomonte P. The interaction between herpes simplex virus 1 genome and promyelocytic leukemia nuclear bodies (PML-NBs) as a hallmark of the entry in latency. Microb. Cell 3(11), 569-572 (2016).
25. Maroui MA, Calle A, Cohen C et al. Latency entry of herpes simplex virus 1 is determined by the interaction of its genome with the nuclear environment. PLoS Pathog. 12(9), e1005834 (2016).
26. Deshmane SL, Fraser NW. During latency herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63(2), 943-947 (1989).
27. Kubat NJ, Tran RK, McAnany P, Bloom DC. Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J. Virol. 78(3), 1139-1149 (2004).
28. Efstathiou S, Minson AC, Field HJ, Anderson JR, Wildy P. Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J. Virol. 57(2), 446-455 (1986).
29. Tirabassi RS, Townley RA, Eldridge MG, Enquist LW. Molecular mechanisms of neurotropic herpesvirus invasion and spread in the CNS. Neurosci. Biobehav. Rev. 22(6), 709-720 (1998).
30. Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe 13(4), 379-393 (2013).
31. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva of normal adults. Invest. Ophthalmol. Vis. Sci. 46(1), 241-247 (2005).
32. Cohrs RJ, Gilden DH, Kinchington PR, Grinfeld E, Kennedy PG. Varicella-zoster virus gene 66 transcription and translation in latently infected human Ganglia. J. Virol. 77(12), 6660-6665 (2003).
33. Wilson AC, Mohr I. A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol. 20(12), 604-611 (2012).
34. Cliffe AR, Wilson AC. Restarting lytic gene transcription at the onset of herpes simplex virus reactivation. J. Virol. 91(2), e01419-16 (2016).
35. Smith G. Herpesvirus transport to the nervous system and back again. Annu. Rev. Microbiol. 66, 153-176 (2012).
36. Sawtell NM, Poon DK, Tansky CS, Thompson RL. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J. Virol. 72(7), 5343-5350 (1998).
37. Catez F, Picard C, Held K et al. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons. PLoS Pathog. 8(8), e1002852 (2012).
38. Lomonte P. Herpesvirus latency: on the importance of positioning oneself. Adv. Anat. Embryol. Cell Biol. 223, 95-117 (2017).
39. Sawtell NM. The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol. 72(8), 6888-6892 (1998).
40. Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin. Exp. Ophthalmol. 44(9), 824-837 (2016).
41. Gnann JW Jr, Whitley RJ. Herpes simplex encephalitis: an update. Curr. Infect. Dis. Rep. 19(3), 13 (2017).
42. Groves MJ. Genital herpes: a review. Am. Fam. Physician 93(11), 928-934 (2016).
43. Bertke AS, Ma A, Margolis MS, Margolis TP. Different mechanisms regulate productive herpes simplex virus 1 (HSV-1) and HSV-2 infections in adult trigeminal neurons. J. Virol. 87(11), 6512-6516 (2013).
44. Looker KJ, Magaret AS, May MT et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob. Health 5(3), e300-e309 (2017).
45. Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N. Engl. J. Med. 361(14), 1376-1385 (2009).
46. Miller CS, Danaher RJ. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 105(1), 43-50 (2008).
47. Amlie-Lefond C, Gilden D. Varicella zoster virus: a common cause of stroke in children and adults. J. Stroke Cerebrovasc. Dis. 25(7), 1561-1569 (2016).
48. Gilden D, Grose C, White T et al. Successful antiviral treatment after 6 years of chronic progressive neurological disease attributed to VZV brain infection. J. Neurol. Sci. 368, 240-242 (2016).
49. Whitley RJ. Herpes simplex virus infections of the central nervous system. Continuum (Minneap Minn), 21(6 Neuroinfectious Disease), 1704-1713 (2015).
50. Goodrum F. Human cytomegalovirus latency: approaching the gordian knot. Annu. Rev. Virol. 3(1), 333-357 (2016).
51. Doll JR, Sawtell NM. Analysis of herpes simplex virus reactivation in explant reveals a method-dependent difference in measured timing of reactivation. J. Virol. 91(16) (2017).
52. Sawtell NM, Thompson RL. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. 66(4), 2150-2156 (1992).
53. Thompson RL, Sawtell NM. The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections. J. Neurovirol. 17(6), 552-558 (2011).
54. Wagner EK, Bloom DC. Experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 10(3), 419-443 (1997).
55. Chen JJ, Gershon AA, Li ZS, Lungu O, Gershon MD. Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J. Med. Virol. 70(Suppl. 1), S71-S78 (2003).
56. Kennedy PG, Rovnak J, Badani H, Cohrs RJ. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J. Gen. Virol. 96(Pt 7), 1581-1602 (2015).
57. Sawtell NM, Thompson RL. Herpes simplex virus and the lexicon of latency and reactivation: a call for defining terms and building an integrated collective framework. F1000Res, 5, 2038 (2016).
58. Pomeranz LE, Reynolds AE, Hengartner CJ. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiol. Mol. Biol. Rev. 69(3), 462-500 (2005).
59. Inman M, Zhou J, Webb H, Jones C. Identification of a novel bovine herpesvirus 1 transcript containing a small open reading frame that is expressed in trigeminal ganglia of latently infected cattle. J. Virol. 78(10), 5438-5447 (2004).
60. Jiang Y, Hossain A, Winkler MT, Holt T, Doster A, Jones C. A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclin-dependent kinase 2 during productive infection. J. Virol. 72(10), 8133-8142 (1998).
61. Yun H, Rowe AM, Lathrop KL, Harvey SA, Hendricks RL. Reversible nerve damage and corneal pathology in murine herpes simplex stromal keratitis. J. Virol. 88(14), 7870-7880 (2014).
62. Kinchington PR, Goins WF. Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models. J. Neurovirol. 17(6), 590-599 (2011).
63. Arvin AM, Moffat JF, Sommer M et al. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. Curr. Top. Microbiol. Immunol. 342, 189-209 (2010).
64. Ku CC, Zerboni L, Ito H, Graham BS, Wallace M, Arvin AM. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J. Exp. Med. 200(7), 917-925 (2004).
65. Gan L, Wang M, Chen JJ, Gershon MD, Gershon AA. Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system. J. Neurovirol. 20(5), 442-456 (2014).
66. Arnold N, Girke T, Sureshchandra S, Messaoudi I. Acute simian varicella virus infection causes robust and sustained changes in gene expression in the sensory ganglia. J. Virol. 90(23), 10823-10843 (2016).
67. Messaoudi I, Barron A, Wellish M et al. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog. 5(11), e1000657 (2009).
68. Sawtell NM, Thompson RL. Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences. J. Virol. 78(14), 7784-7794 (2004).
69. Thellman NM, Triezenberg SJ. Herpes simplex virus establishment, maintenance, and reactivation: in vitro modeling of latency. Pathogens 6(3), 28 (2017).
70. Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl Acad. Sci. USA 74(12), 5716-5720 (1977).
71. Reardon JE, Spector T. Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. J. Biol. Chem. 264(13), 7405-7411 (1989).
72. Wilcox CL, Johnson EM Jr. Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J. Virol. 61(7), 2311-2315 (1987).
73. Wilcox CL, Smith RL, Freed CR, Johnson EM Jr. Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J. Neurosci. 10(4), 1268-1275 (1990).
74. Camarena V, Kobayashi M, Kim JY et al. Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. Cell Host Microbe 8(4), 320-330 (2010).
75. Kobayashi M, Wilson AC, Chao MV, Mohr I. Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor. Genes Dev. 26(14), 1527-1532 (2012).
76. Michaelevski I, Segal-Ruder Y, Rozenbaum M et al. Signaling to transcription networks in the neuronal retrograde injury response. Sci. Signal. 3(130), ra53 (2010).
77. Perry RB, Doron-Mandel E, Iavnilovitch E et al. Subcellular knockout of importin beta1 perturbs axonal retrograde signaling. Neuron 75(2), 294-305 (2012).
78. Liu WW, Goodhouse J, Jeon NL, Enquist LW. A microfluidic chamber for analysis of neuron-to-cell spread and axonal transport of an alpha-herpesvirus. PLoS ONE 3(6), e2382 (2008).
79. Koyuncu OO, MacGibeny MA, Hogue IB, Enquist LW. Compartmented neuronal cultures reveal two distinct mechanisms for alpha herpesvirus escape from genome silencing. PLoS Pathog. 13(10), e1006608 (2017).
80. Koyuncu OO, Song R, Greco TM, Cristea IM, Enquist LW. The number of alphaherpesvirus particles infecting axons and the axonal protein repertoire determines the outcome of neuronal infection. mBio 6(2), e00276-15 (2015).
81. Koyuncu OO, Perlman DH, Enquist LW. Efficient retrograde transport of pseudorabies virus within neurons requires local protein synthesis in axons. Cell Host Microbe 13(1), 54-66 (2013).
82. Jung H, Yoon BC, Holt CE. Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat. Rev. Neurosci. 13(5), 308-324 (2012).
83. Michaelevski I, Medzihradszky KF, Lynn A, Burlingame AL, Fainzilber M. Axonal transport proteomics reveals mobilization of translation machinery to the lesion site in injured sciatic nerve. Mol. Cell Proteomics 9(5), 976-987 (2010).
84. Song R, Koyuncu OO, Greco TM, Diner BA, Cristea IM, Enquist LW. Two modes of the axonal interferon response limit alphaherpesvirus neuroinvasion. mBio 7(1), e02145-e02115 (2016).
85. Enquist LW, Leib DA. Intrinsic and innate defenses of neurons: detente with the herpesviruses. J. Virol. 91(1), e01200-16 (2017).
86. Schoggins JW. Interferon-stimulated genes: roles in viral pathogenesis. Curr. Opin. Virol. 6, 40-46 (2014).
87. Cunningham AL, Mikloska Z. The Holy Grail: immune control of human herpes simplex virus infection and disease. Herpes 8(Suppl. 1), 6A-10A (2001).
88. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189(4), 663-672 (1999).
89. St Leger AJ, Hendricks RL. CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation. J. Neurovirol. 17(6), 528-534 (2011).
90. Mikloska Z, Cunningham AL. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J. Virol. 75(23), 11821-11826 (2001).
91. De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW. Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS ONE 5(9) (2010).
92. Linderman JA, Kobayashi M, Rayannavar V et al. Immune escape via a transient gene expression program enables productive replication of a latent pathogen. Cell Rep. 18(5), 1312-1323 (2017).
93. Cai W, Schaffer PA. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J. Virol. 66(5), 2904-2915 (1992).
94. Moriuchi H, Moriuchi M, Dean H, Cheung AK, Cohen JI. Pseudorabies virus EPO is functionally homologous to varicella-zoster virus ORF61 protein and herpes simplex virus type 1 ICPO. Virology 209(1), 281-283 (1995).
95. Danaher RJ, Savells-Arb AD, Black SA Jr, Jacob RJ, Miller CS. Herpesvirus quiescence in neuronal cells IV: virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway. J. Neurovirol. 7(2), 163-168 (2001).
96. Rodriguez A, Sainz De La Maza M, Missry J, Foster CS. The role of cyclic nucleotide mediators in latency and reactivation of HSV-1 infected neuroblastoma cells. Eye 5(Pt 5), 627-635 (1991).
97. Cliffe AR, Arbuckle JH, Vogel JL et al. Neuronal stress pathway mediating a histone methyl/phospho switch is required for herpes simplex virus reactivation. Cell Host Microbe 18(6), 649-658 (2015).
98. Thompson RL, Sawtell NM. Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency. Future Med. Chem. 2(7), 1099-1105 (2010).
99. Thompson RL, Sawtell NM. Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency. J. Virol. 74(2), 965-974 (2000).
100. Sawtell NM, Thompson RL. De novo herpes simplex virus VP16 expression gates a dynamic programmatic transition and sets the latent/lytic balance during acute infection in trigeminal ganglia. PLoS Pathog. 12(9), e1005877 (2016).
101. Kim JY, Mandarino A, Chao MV, Mohr I, Wilson AC. Transient reversal of episome silencing precedes VP16-dependent transcription during reactivation of latent HSV-1 in neurons. PLoS Pathog. 8(2), e1002540 (2012).
102. Cliffe AR, Garber DA, Knipe DM. Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J. Virol. 83(16), 8182-8190 (2009).
103. Taylor MP, Kobiler O, Enquist LW. Alphaherpesvirus axon-to-cell spread involves limited virion transmission. Proc. Natl Acad. Sci. USA 109(42), 17046-17051 (2012).